VectorY

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$137.8M

VectorY Therapeutics is a biotech company focused on developing vectorized antibody therapies for neurodegenerative diseases, with a lead program targeting Amyotrophic Lateral Sclerosis (ALS).